Efficacy, immunogenicity and safety of the AS04‐HPV‐16/18 vaccine in Chinese women aged 18‐25 years: End‐of‐study results from a phase II/III, randomised, controlled trial - Concepedia

Concepedia

Publication | Open Access

Efficacy, immunogenicity and safety of the AS04‐HPV‐16/18 vaccine in Chinese women aged 18‐25 years: End‐of‐study results from a phase II/III, randomised, controlled trial

DOI Full Paper Access

56

Citations

39

References

2019

Year

Fengcai Zhu, Shangying Hu, Ying Hong, Yuemei Hu, Xun Zhang, Yiju Zhang, Qin‐Jing Pan, Wen‐Hua Zhang, Fanghui Zhao, Chengfu Zhang,

Cancer Medicine

Abstract

NCT00779766.

References

	Year	Citations

Page 1